Neurology
Video
VIDEO: Novel sphingosine 1-phosphate 1 receptor modulator has promising safety results
Conference Coverage
Interferon beta-1a, glatiramer acetate prove cost effective for long-term MS treatment
Key clinical point: Treatment with either glatiramer acetate or interferon beta-1a alters the natural history of relapsing-remitting MS in the...
Conference Coverage
Phase II RADIANCE study results demonstrate efficacy of RPC1036 in MS
Key clinical point: The first clinical trial of the novel oral sphingosine 1-phosphate 1 receptor modulator RPC1063 in patients with relapsing MS...
News
AEDs perform largely the same in reducing secondary generalized tonic-clonic seizures
Key clinical point: Add-on therapy with AEDs may reduce the risk of secondary generalized tonic-clonic seizures in patients with drug-resistant...
Conference Coverage
Factors may identify high-risk patients with clinically isolated syndrome
Key clinical point: Risk factor recognition helps in the identification of patients who have clinically isolated syndrome and may benefit from...
Conference Coverage
Alemtuzumab safety and efficacy persist at 4 years in relapsing-remitting multiple sclerosis
Key clinical point: Alemtuzumab appears to be associated with a low rate of sustained accumulation of disability in relapsing-remitting multiple...
News
VIDEO: Predicting time to relapse after CIS in largest-ever study of high-risk patients
Video
VIDEO: Grants launch large-scale collaboration against progressive MS
Video
VIDEO: Axial MRI better identifies extent of MS lesions in the cervical spinal cord
News
Autonomic symptoms may contribute to MS-related fatigue
Key clinical point: Patients with relapsing-remitting MS and low disability have autonomic symptoms, particularly orthostatic intolerance, that...